Rhythm Pharmaceuticals Inc (RYTM)
42.34
-0.33
(-0.77%)
USD |
NASDAQ |
Jul 02, 16:00
42.34
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Gross Profit (TTM): 81.24M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 81.24M |
December 31, 2023 | 68.13M |
September 30, 2023 | 54.89M |
June 30, 2023 | 38.58M |
March 31, 2023 | 30.28M |
December 31, 2022 | 21.50M |
September 30, 2022 | 15.32M |
Date | Value |
---|---|
June 30, 2022 | 12.34M |
March 31, 2022 | 3.792M |
December 31, 2021 | 2.555M |
September 30, 2021 | 0.974M |
June 30, 2021 | 0.168M |
March 31, 2021 | 0.031M |
December 31, 2020 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
Dec 2020
81.24M
Maximum
Mar 2024
23.56M
Average
13.83M
Median
Gross Profit (TTM) Benchmarks
Pfizer Inc | 31.64B |
Amgen Inc | 19.60B |
Amicus Therapeutics Inc | 379.54M |
Viking Therapeutics Inc | -- |
Arvinas Inc | -- |